Brilinta Beats Plavix in Onset of Action Post-PCI (CME/CE)
(MedPage Today) -- Pharmacodynamic study suggests advantage for ticagrelor (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 9, 2016 Category: Cardiology Source Type: news
Long-Term Plavix Tx Linked to ACS Risk
(MedPage Today) -- Stent thrombosis, other adverse outcomes more common with chronic treatment (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 31, 2016 Category: Cardiology Source Type: news
Genetics Home Reference: clopidogrel resistance
http://ghr.nlm.nih.gov/condition/clopidogrel-resistance (Source: NLM General Announcements)
Source: NLM General Announcements - December 29, 2015 Category: Databases & Libraries Source Type: news
Similar Low Cancer Rates With Two DAPT Strategies in TRILOGY ACSSimilar Low Cancer Rates With Two DAPT Strategies in TRILOGY ACS
New cancers occurred infrequently in patients with unstable angina or MI, and the rates were comparable in those taking dual antiplatelet therapy with aspirin plus prasugrel or clopidogrel. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 18, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
How Your Genes Influence What Medicines Are Right for You
This article was originally published on The Conversation. Read the original article. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - November 22, 2015 Category: Consumer Health News Source Type: news
CANOA: Clopidogrel Reduces Migraine After ASD ClosureCANOA: Clopidogrel Reduces Migraine After ASD Closure
The study provides definitive data that dual antiplatelet therapy leads to fewer migraines after transcatheter closure of an atrial septal defect, the lead author says. Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2015 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
FDA: Long-Term Clopidogrel Doesn't Affect Mortality Rates in Heart Patients (FREE)
By Kristin J. Kelley
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
Long-term treatment with clopidogrel (Plavix) doesn't increase or decrease the overall risk for death in patients with, or at risk for, heart disease, according to the results of an … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 8, 2015 Category: Primary Care Source Type: news
FDA: No Long-Term Clopidogrel Mortality, Cancer Risks FDA: No Long-Term Clopidogrel Mortality, Cancer Risks
In today's MedWatch, the agency reports results from its meta-analyses, which included a review of DAPT and other large clinical trials that examined adverse events from clopidogrel use. News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 7, 2015 Category: Cardiology Tags: Cardiology News Alert Source Type: news
No Lives Saved With Extended Plavix Use
(MedPage Today) -- FDA issues long awaited safety decision. Is anyone listening? (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 6, 2015 Category: Cardiology Source Type: news
Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death
FDA review determines that long-term use of clopidogrel does not increase/decrease overall risk of death in patients with, or at risk for, heart disease, and does not suggest that clopidogrel increases risk of cancer/death from cancer. (Source: FDA MedWatch)
Source: FDA MedWatch - November 6, 2015 Category: American Health Source Type: news
Aspirin-Free Tx After PCI Won't Up Bleeding Risk (CME/CE)
(MedPage Today) -- But stopping aspirin may be "deleterious" in nonresponders to clopidogrel (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 19, 2015 Category: Cardiology Source Type: news
OPTIDUAL: More Debate on Length of Dual Antiplatelet Therapy Post-DESOPTIDUAL: More Debate on Length of Dual Antiplatelet Therapy Post-DES
Another trial of extended clopidogrel has done little to settle the confusion about how long dual antiplatelet therapy should be continued following drug eluting stent placement. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 31, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets
Unichem Pharmaceuticals (USA), Inc. (Unichem) is voluntarily recalling one lot of Hydrochlorothiazide Tablets 25 mg 1000-count bottle to the consumer level. This recall has been initiated as a precautionary measure due to the identification of a Clopidogrel tablet found in a bottle of the product. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 1, 2015 Category: Food Science Source Type: news
Your NEJM Group Today: Politics of Clean Needles, PPIs & Clopidogrel, Maine GI Opportunity (FREE)
By the Editors
NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM Audio … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 30, 2015 Category: Primary Care Source Type: news
Meta-analysis Reassures on Clopidogrel With PPIsMeta-analysis Reassures on Clopidogrel With PPIs
Investigators say any increased ischemic risks observed among clopidogrel-treated patients who receive a PPI has more to do with their baseline comorbidities than a real finding. Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 8, 2015 Category: Consumer Health News Tags: Cardiology News Source Type: news
